BCL-2 expression was significantly higher in neuroblastoma cells compared with other solid tumor cell lines, and BCL-xL expression was significantly reduced in neuroblastoma cells, resulting in a high BCL-2:BCL-xL ratio (Figure 3A). The gene discussed is BCL2L1; the disease is neuroblastoma.